Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Alopecia areata in Dubai mostly affects men, often involves autoimmune disorders, and has high healthcare costs, especially for psychological issues.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

Ginsenoside Rd may help improve skin aging by increasing collagen in the skin.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

lncRNAs are important for understanding and treating skin diseases.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Researchers developed a 3D model of human hair follicle cells that can help understand hair growth and test new hair loss treatments.

Aromatic plants can naturally help prevent skin aging and improve skin health.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Upadacitinib may cause hair loss.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

New treatments for severe alopecia areata show promise but lack standard approval.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Upadacitinib improved multiple immune-related conditions in one patient.